|
THE CAPABILITY EDGE — OCT 2026 Structure, pace, and opportunity — What thirty years of design reviews and one software paper agree onA paper has been sitting on my desk for a few weeks, written by Kemerer and Paulk (IEEE Transactions on Software Engineering, 2009), about a large study of what makes technical reviews effective. They concluded that well-structured, well-paced code reviews found substantially more defects than unstructured, poorly paced reviews. The authors stated the underlying point this way: “The quality of the work products depends upon the quality control mechanisms we employ as an integral part of our processes.” Quality control mechanisms are an integral part of the process, not simply inspections layered on top afterward. To be clear, the IEEE paper was about software and software code reviews. I am not interested in the specific code review rates from the paper, or how fast was too fast to get good code. Nor am I going to pretend the study transfers to reviewing drawings, specifications, and test protocols. But I have spent three decades sitting in design reviews, and I would tell you the overarching concepts hold true. The reviews I have seen catch real problems had structure, pace, and opportunity. The ones that produced a signature and nothing else had none of the three. So here is what those words actually mean to a medical device design review. StructureA structured design review knows what it is doing before it starts.
PaceA well-paced review gives people enough time with the material to actually see it.
The design review is usually required, auditable, and leaves a record. Preparation is none of those things. So, when a project runs tight, nobody cancels the design review. They cut the reading. However, the record still gets signed, and nothing shows what was lost. Which is why opportunity matters, and why it is the issue nobody writes into a procedure. Structure and pace are things a team can impact. Opportunity is something a team has to be given. OpportunityOpportunity means the design team has cover, time, and visible leadership support to conduct a thorough review. Not permission in a procedure, but permission in practice. The IEEE paper’s authors made a similar observation, and it is the sentence I keep returning to: “Within a deadline-driven business context, it is easy to see examples of the tendency to take shortcuts, which, while perhaps meeting a short-term schedule goal, have clear implications for raising future costs of maintenance and customer support for the resulting lower-quality software.” That is software engineering from 2009, describing one reason why project teams get formed to fix on-market devices. Here is what it looks like when the opportunity is real:
Organizational culture is not a soft factor here. If time to market, or worse, time to an arbitrary milestone is the only thing that is measured, then quality goes out the window, and no amount of structure in your procedure will fix it. Why it is worth protectingA design review is the cheapest place in a program to find a problem. Nothing is built, no tooling is cut, nothing has been verified. The same issue found at verification costs a protocol rerun. Found after submission, it costs a deficiency response and a launch date. Structure, pace, and opportunity are not quality overhead. They are the difference between paying once and paying twice. I’ve written separately about what that difference adds up to across a program. Design Review (DR) scorecardThe DR scorecard measures structure and pace. Twenty questions across five dimensions: (1) preparation and planning, (2) reviewer composition and independence, (3) content coverage and traceability, (4) conduct and rigor, (5) follow-through and closure, scored out of 100. Use it on a DR you have already held. It takes about fifteen minutes. Tell me what you found. Opportunity is not in it, deliberately. You cannot score your leadership’s appetite for bad news from a DR, and you wouldn’t want that written down and kept in a design file. Opportunity shows up a different way: run the scorecard across your last five reviews and look at the trend. One weak review may lead to a poor design. The same weak scorecard dimension five times is not a DR problem. It is what the organization is actually asking for.
Next month: The Capability Edge LiveA free three-part series, 10–12 November, 45 minutes a day at noon Eastern. Day one picks up exactly where this issue stops: the gaps an experienced reviewer sees in a design file. Day two is what those gaps cost. Day three shows you how to build the capability that closes them. Register, and the scorecard and the Training ROI Calculator come with it. Register: design-quality-services.kit.com/capability-edge-live Also in November: MEDevice Silicon ValleyWe’ll be at booth 940 in Santa Clara on 18–19 November. If your design reviews are the thing you keep meaning to fix, bring a review record, and we’ll go through it at the booth. That conversation works better in person than by email. Source Kemerer CF, Paulk MC. “The Impact of Design and Code Reviews on Software Quality: An Empirical Study Based on PSP Data.” IEEE Transactions on Software Engineering, Vol. 35, 2009. Both quotations are verbatim. The edge isn’t knowing the regulation. It’s implementing it. John Salvato, PhD - Founder & President, Design Quality Services
|
John Salvato, Ph.D., Founder & President — Design Quality Services DQS helps medical device teams move beyond compliance and build real capability — stronger designs, fewer rework cycles, better submission outcomes. Recognized as a Top Medical Device Consulting firm by MedTech Business Review, 2026. Knowledge is the shortest path between ingenuity and impact.
The Capability Edge — September 2026 The Cost of Training Is Visible. The Cost of Insufficient Capability Often Is Not. When organizations begin tightening budgets, professional development is frequently treated as a discretionary expense. The reasoning is understandable: training has a visible and immediate cost, while its financial return can be difficult to isolate. In medical device development, however, that framing is incomplete. The more useful economic question is not simply what it...
Why Quality Problems Keep Repeating in Medical Device Organizations Every medical device organization wants to produce safe, effective products while satisfying increasingly rigorous regulatory expectations. Yet many companies continue to experience the same quality problems repeatedly. CAPAs recur. Design reviews uncover familiar deficiencies. FDA observations identify issues that leadership believed had already been resolved. Despite extensive procedures, documented quality systems, and...